Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · IEX Real-Time Price · USD
5.99
-0.01 (-0.17%)
At close: Apr 17, 2024, 4:00 PM
6.19
+0.20 (3.34%)
After-hours: Apr 17, 2024, 6:45 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $64.34 million as of April 17, 2024. Its market cap has increased by 21.63% in one year.
Market Cap
64.34M
Enterprise Value
22.01M
1-Year Change
21.63%
Ranking
Category
Stock Price
$5.99
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $90.20M to $64.34M, a decrease of -28.67%. That is a compound annual growth rate of -8.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 64.40M | 0.47% |
Apr 15, 2024 | 64.10M | -6.56% |
Apr 12, 2024 | 68.60M | -4.19% |
Apr 11, 2024 | 71.60M | -13.84% |
Apr 10, 2024 | 83.10M | -0.36% |
Apr 9, 2024 | 83.40M | -0.36% |
Apr 8, 2024 | 83.70M | 0.36% |
Apr 5, 2024 | 83.40M | 7.47% |
Apr 4, 2024 | 77.60M | -16.38% |
Apr 3, 2024 | 92.80M | -5.60% |
Apr 2, 2024 | 98.30M | -3.72% |
Apr 1, 2024 | 102.10M | 8.04% |
Mar 28, 2024 | 94.50M | -10.09% |
Mar 27, 2024 | 105.10M | -2.41% |
Mar 26, 2024 | 107.70M | 1.03% |
Mar 25, 2024 | 106.60M | -6.82% |
Mar 22, 2024 | 114.40M | 17.94% |
Mar 21, 2024 | 97.00M | 2.65% |
Mar 20, 2024 | 94.50M | 17.39% |
Mar 19, 2024 | 80.50M | -24.77% |
Mar 18, 2024 | 107.00M | 13.11% |
Mar 15, 2024 | 94.60M | 18.40% |
Mar 14, 2024 | 79.90M | 6.68% |
Mar 13, 2024 | 74.90M | -10.51% |
Mar 12, 2024 | 83.70M | 21.83% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Immix Biopharma | 67.44M |
Palisade Bio | 67.44M |
Landos Biopharma | 67.23M |
Rallybio | 66.14M |
Mural Oncology | 65.94M |
Pro-Dex | 65.66M |
Marinus Pharmaceuticals | 65.04M |
MDxHealth | 64.95M |